This hydroxylation process allows the HIF-1α recognition by the von Hippel-Lindau (pVHL), a kind of tumor-suppressor protein and the substrate recognition component of an E3 ubiquitin ligase complex that aims HIF-α for proteasomal degradation42,43. The gene discussed is HIF1A; the disease is neoplasm.